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Questa è la versione post-print dell’articolo “Adherence to European Society for 
Cataract and Refractive Surgery recommendations amongst Italian cataract surgeons: a 
survey”  degli autori Grosso A, Pertile G, Marchini G, Scarpa G, Ceruti P, Prigione G, 
Romano MR, Bert F, Gili R, Panico C, Siliquini R, Engelbert M, pubblicato come Original 
Paper sulla rivista European Journal of Ophthalmology.  
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ABSTRACT 
Title: Adherence to European Society for Cataract and Refractive Surgery recommendations 
amongst Italian cataract surgeons: a survey  
Running title: Prevention of endophthalmitis after cataract surgery in Italy 
PURPOSE: To survey the surgical routines with regards to prophylactic strategies in a sample of 
Italian Hospitals and compare these with the  European Society for Cataract and Refractive Surgery 
(ESCRS) guidelines. 
SETTING: clinical-based study. 
DESIGN: questionnaire-based survey, retrospective study 
METHODS: Six private and 18 public Hospitals participated to this Survey.  
 Patient or study population: the overall volume of cataract operations in the 24 centres in 
 2013 was 43553. 
 Intervention or Observation Procedure(s): cataract surgery 
 Main outcome measures: Incidence of endophthalmitis per 1000. An incidence of less then 
 0.13% was considered acceptable. 
RESULTS: Our study provides the first Italian data on the use of intracameral antibiotics in cataract 
surgery, as recommended by the ESCRS. Thirteen centres (54%) used intracameral cefuroxime at 
the end of surgery. Of the 13 centers that used cefuroxime, 8 (62%)  had an incidence of 
endopthalmitis less then 0.13%. Of the 7 (29%) centres that did not use intracameral cefuroxime, all 
had and endopthalmitis rate of greater than 0.13%. This difference was statistically significant (p< 
0.05). Among the 4 centers not included, 2 have used vancomycin, one a quinolone, and the last a 
combination of antibiotics. The majority of surgeons (79%) did use preoperative antibiotic eyedrops 
and 63% of them have recommended topical fluorquinolones but this measure was not shown 
protective. No differences in the incidence of post-cataract endophthalmitis between high and low-
volume sites was demonstrated. 
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CONCLUSIONS 
Only little more than half of the centers surveyed in this study adhered to the recommendations of 
the ESCRS and routinely employed prophylactic intracameral cefuroxime. An incidence of 
endophthalmitis greater than 0.13% was encountered significantly more frequently amongst centres 
that did not employ intracameral cefuroxime.  
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INTRODUCTION 
Endophthalmitis remains one of the most challenging and devastating complications faced by the 
ophthalmologist.
1-8
 Post-cataract endophthalmitis (POE) incidence ranges from 0.04% to 0.13% 
with differences in regional microbiological spectrum.
9-16
 
The European Society for Cataract and Refractive Surgery (ESCRS) has recently updated its 
recommendations for prevention and management of post-cataract endophthalmitis.
17, 18
 Since the 
routine introduction of intracameral injection of cefuroxime 6 years ago, the rate of endophthalmis 
has been significantly reduced.
19-25
 Furthermore, a commercially available formulation of 
cefuroxime (Aprokam
®
) approved for intracameral prophylaxis was introduced to the European 
market in 2013. 
Recently, the Italian Society of Ophthalmology issued recommendations to prevent endophthalmitis 
following cataract surgery but left antibiotic use to the individual surgeon’s discretion.26 
What the “choosing wisely” paradigm in medicine would imply for perioperative prophylaxis in 
cataract surgery remains controversial,
27 
because surgical settings, techniques and preferences may 
be different in various settings. Topical preoperative antibiotics remain popular despite the 
recognition that overuse and repeated exposure to topical antibiotics can lead to the emergence of 
bacteria that do not respond readily to available treatments. Mounting evidence suggests that ocular 
surface organisms are becoming more resistant to fluoroquinolones, with up to 30% of cultured 
ocular isolates being resistant.
28-32
Also, the efficacy and safety profile of intracameral cefuroxime 
during cataract surgery remain controversial since there are conflicting results in the literature about 
the additional protective effect of cefuroxime when added to the standard of care. 
17,18,33,34
.  
The purpose of our study was to conduct a survey to collect data on the attitudes and methods used 
to prevent post-cataract endophthalmitis in a list of selected Italian hospitals and to compare 
practice with ESCRS guidelines and best available evidence. 
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METHODS 
A multiple choice questionnaire-based survey was designed  to get a broad cross-section of 
different settings across the country: six private and 18 public Italian Hospitals participated to this 
Survey. 
Among public hospitals, 10 were teaching hospitals. Institutional Review Board approval was 
obtained at the single institution for retrospective review of identified patient records. 
The incidence of endophthalmitis was established from a retrospective analysis of a coding database 
at the respective institution (number of postoperative endophthalmitis codes/number of cataract 
surgery codes at that institution). An incidence of post cataract endophthalmitis of less than 0.13% 
was choosen as an acceptable level of endophthalmitis, 
35
 since a systematic review found an 
aggregate incidence of endophthalmitis occurring after cataract surgery of 0.13.
13
  
The purpose of the first part of the questionnaire was to collect information about the surgical 
routines with regards to prophylactic strategies.  
The purpose of the second part of the questionnaire was to determine the incidence of 
endophthalmitis after cataract surgery in the year 2013 in each Hospital and to assess whether the 
ESCRS recommendations with regards  intracameral cefuroxime where adhered to. Furthermore, 
allergic or toxic reactions with intracameral cefuroxime were inquired about. 
 Statistical Analysis The results were analyzed using the StataMP11 statistical software 
(Stata Corp., College Station, TX, 2011). Firstly, a descriptive analysis of the centres was 
conducted, considering the the annual cataract volume, the number of infectious endophtalmitis 
cases per 1000 cataracts, the geographic area and the hospital type. Results were expressed in 
frequencies and percentages. Endophthalmitis incidences at the various participating institutions 
were dichotomized as < 0.13% versus > 0.13%. A descriptive analysis of the use of perioperative 
antibiotics and/or intracameral antibiotics, the use of antimicrobial drugs at the end of surgery, 
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possible side effects and the use of postoperative antibiotics, was then carried out. 
Finally, a multivariate analysis was performed in order to highlight which outcomes were related 
with a rate of endophtalmitis higher or less than the expected acceptable value of 0.13%. For all 
analyses the alpha level was set at 0.05. 
36
 
RESULTS 
Our survey mirrors the preferred practice patterns to prevent post-cataract endophtalmitis among a 
spectrum of private and academic setttings with varying surgical volumes in 2013.  
The overall volume of cataract operations in the 24 centres in 2013 was 43,553.  
 Centres’ characteristics are shown in Table 1: 8 hospitals were public, 10 were academic and 6 
private operating within the Italian National Health System. In the table we provide readers with 
volume of cataract operations. Eleven centres showed an incidence of post-cataract endophtalmitis 
lower than 0.13% and 13 centres showed an incidence higher than 0.13%.  
Table 2 shows the methods used to prevent post-operative endophtalmitis.  All surgeons declared to 
use preoperative conjuctival povidone-iodine. The use of subconjunctival antibiotics was not 
reported and only in two centres vancomycin was used in the infusion bottle. The majority of 
surgeons (79%) did use preoperative antibiotic eyedrops and 63% of them have recommended to 
start a perioperative topical antibiotic 3 days before the scheduled cataract surgery. Fluorquinolones 
were the preferred preoperative topical antibiotics for cataract surgery (ofloxacin, ciprofloxacin and 
levofloxacin, in order of frequency). Thirteen centres (54%) used intracameral cefuroxime at the 
end of surgery. Surgeons declared to have used more than one antibiotic as a post-operative 
prophylaxis according to local microbiological surveillance (chloramphenicol + fluoroquinolones, 
netilmicin + fluorquinolones). The majority of cataract surgeons did not taper antibiotics during 
follow up. 
Table 3 shows the association of endophthalmitis by therapy used. Thirteen centres (54%) used 
intracameral cefuroxime at the end of surgery. Of the 13 centers that used cefuroxime, 8 (62%)  had 
an incidence of endopthalmitis less then 0.13%. Of the 7 (29%) centres that did not use intracameral 
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cefuroxime, all had and endopthalmitis rate of greater than 0.13%. This difference was statistically 
significant (p< 0.05). Among the 4 centers not included, 2 have used vancomycin, one a quinolone, 
and the last a combination of antibiotics. In the centres where vancomycin was used the incidence 
of endophtalmitis was lower than 0.13% only in one. In the centre where a fluoroquinolone was 
used and in the centre where a combination of cefuroxime + vancomycin was used the incidence of 
endophthalmitis was found lower than 0.13%.  
The incidence of endophthalmitis was not associated with the use of preoperative antibiotics nor 
with a specific molecule. Our data showed no differences in the incidence of post-cataract 
endophthalmitis between high and low-volume centres. 
DISCUSSION 
We present information on current prophylactic antibiotic use for cataract surgery in Italy.  
Despite the existence of internationally validated standardized protocols, there is heterogeneity 
regarding the surgeon’s attitudes to prevent endophthalmitis in the real world. All surgeons agree on 
the use of topical 5% povidone-iodine solution to prepare the conjunctiva for three minutes before 
surgery and povidone-iodine for the skin. In a recent prospective clinical study it was shown that 
ocular surface preparation using povidone-iodine 5% alone in the absence of postinjection topical 
antibiotics does not promote bacterial resistance or changes in conjunctival flora.
28 
 However, it is controversial whether preoperative antibiotics or intracameral cefuroxime 
play a role in the routine prophylaxis of post-cataract endophthalmitis.
 27-34
 The majority of Italian 
cataract surgeons use topical fluoroquinolones in the perioperative period. In our survey, the use of 
perioperative antibiotics does not have a protective effect. The overuse and repeated exposure to 
antibiotics may lead to the emergence of bacteria that do not respond readily to available 
treatments. Mounting evidencesuggests that ocular surface organisms are becoming more resistant 
to fluoroquinolones, 
27-32
 with up to 30% of cultured ocular isolates being resistant. In the era of 
“choosing wisely” and “antimicrobial stewardship” paradigms,27 the importance of appropriate 
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antibiotic use needs to be emphasized: according to a recent study topical antibiotical therapy was 
equally effective in reducing the conjunctival bacterial load whether given 1 day or 1 hour before 
surgery.
37
  
Our survey provides the first Italian data on the use of intracameral antibiotics in cataract surgery. 
There is already strong evidence that intracameral prophylaxis with cefuroxime may be effective in 
lowering the incidence of endophthalmitis.
 17-25, 38
 The ESCRS has been recommending to 
administer cefuroxime in the anterior chamber in all cases of cataract surgery since 2007.
17-19
 
However,  the additional protective role of cefuroxime over the standardized protocols is still a 
matter of debate. In our survey, cefuroxime does seem to have a protective effect. Given the low 
rate of incidence of endophthalmitis, it is difficult to demonstrate a greater efficacy of a preventive 
protocol that includes intracameral cefuroxime versus a prohylactic protocol that does not include 
cefuroxime: however, when the ESCRS guidelines are followed, 62% of centres that routinely use 
intracameral cefuroxime had an incidence of post-cataract endophthalmitis lower than the 
acceptable 0.13% and similarly acceptable rates were found significantly less frequently amongst 
centers that did not routinely employ intracameral cefuroxime. Nevertheless, in 5 centres that 
routinely used intracameral cefuroxime the incidence of post-cataract endophthalmitis was higher 
than 0.13%. There may have been other factors other than just intracameral antibiotics that 
contributed to higher endophthalmitis rates: the use of perioperative topical antibiotics (type of 
molecule and duration of prophylaxis), and the clinical characteristics of the patients operated. 
In the sample of selected hospitals included in this survey only thirteen centres (54%) used 
intracameral cefuroxime at the end of surgery. However, with pre-formulated cefuroxime now 
being readily available, the number of Italian cataract surgeons who use cefuroxime is increasing as 
shown in table 2.  The intracameral use may have gained slow acceptance by surgeons in Italy over 
other ways of administration of antibiotics (subconjuctival or in the influsion bottle) 
9,10
 for 
technical reasons (risk of dilution errors, and bacterial contamination) and concerns about 
endothelial corneal toxicity.  
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The important clinical question is whether cefuroxime may be the antibiotic of choice to prevent 
post-cataract endophthalmitis. The identification of cefuroxime as ideal prophylactic antibiotic to 
cover the most frequent microbiological pathogens derive from the conclusion of the 
Endophthalmitis Vitrectomy Study (1995).
38
 Microbiological surveillance is mandatory to 
understand the current role of cefuroxime. When we compare the microbiological surveillance
39-44, 
 
among different studies in US and Europe, the list of germs involved is quite stable and similar with 
the majority of them belonging to Gram +: coagulase-negative Staphylococci, Staphyloccocus 
aureus,  alpha-hemolytic streptococci, and Streptococcus pneumoniae. Among Gram - 
Pseudomonas spp, enterobactriaceae, Haemophilus influenzae, Moraxella, and Klebsiella. 
Microbiological variations in infectious agents are secondary to differences in climate (i.e fungal 
infections) or organization (different health systems). In a previous report of ESCRS in 2007 only 
Gram + germs were isolated.
17
 A recent microbiological review 
35 
of all culture proven cases of 
endophthalmitis in the last 25 years at one large institution appears to support cefuroxime versus 
cefazolin and/or other antibiotics that have higher resistant rates. Endophthalmitis isolates have had 
a significant trend toward both increasing resistance to cephalosporins and Methicillin and 
decreasing resistance to aminoglycosides and Imipenem. On the other hand Vancomycin has been 
shown to be effective towards Gram + germs but ineffective towards Gram – germs. Therefore 
Vancomycin
42
 should be used as second line agent, also because it is effective against resistant 
strains of Staphyloccocus aureus (MRSA). As far the allergic or toxic reactions are concerned it 
was recently reported
45
 that a patient developed an anaphylactic reaction several minutes after 
intracameral injection of cefuroxime at the end of uneventful phacoemulsification and intraocular 
lens implantation surgery. In our survey 50% of surgeons were concerned about toxic or allergic 
reactions.  
Choosing wisely also is a patient specific choice.  For example, elderly patients with blepharitis, 
poor tear film, anticipated prolonged surgery, may be more prone to infection and therefore good 
candidates for  intracameral or preoperative antibiotics.  
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 There is a growing debate on the definition and the inclusion of immunocompromised patients, 
such as those with diabetes, cancer or long term treatment with steroids, history of trauma or 
previous ocular surgery: it would be of clinical interest investigate whether a correlation between 
specific types of germs and immunodepression may be demonstrated.  
Cost-effectiveness analyses are also warranted. A retrospective study carried out at University of 
Udine, Italy in 2013  showed that the use of commercially available intracameral antibiotics is not 
cost-effective in the prevention of post-cataract endophthalmitis compared to the costs of 
vitrectomy for endophthalmitis, given the rare occurrence of post-cataract endophthalmitis. (Prof. 
P. Lanzetta and coworkers personal communication, Pordenone, Italy, September 2014). 
Strenghts of our study are the enrollment of a variety of private, public, and academic settings 
across Italy.This is the first Italian survey on the subject to employ email interviews for data 
collection. The method offers advantages over postal surveys and telephone interviews, as direct 
dialogue between the epidemiologists (FB, RG, RS), the principal investigator (AG) and cataract 
surgeons (complete list reported in the appendix) allows clarification of answers, additional queries 
and leaves time for a better retrospective analysis.  Each centre involved in the survey was totally 
blind regarding the participation of the other centres.  
Limitations include the retrospective nature of our study. There may have been other factors than 
just intracameral antibiotics that contributed to lower endophthalmitis rates. Randomized controlled 
trials, with rare outcomes require very large sample sizes and are costly or even cost-prohibitve to 
conduct. Further we could not perform a Health Technology Assessment analysis given the absence 
of uniform data and sufficient studies. We are aware that case control studies or models should have 
provided more solid scientific data than a survey. A high cut point for an "acceptable" level of 
endophthalmitis was decided (0.13%): in a systematic review an aggregate incidence of 
endophthalmitis occurring after cataract surgery of 0.128% was found.
13
. Further the cut-off 
decided in our survey was lower than the level found in the Cefuroxime study.
17
  We are aware that 
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it would have been desirable to have a lower than reported average level of endophthalmitis: 
however dealing with rare clinical events the choice of lower cut point may have weakened the 
association. 
 In conclusion, when we compare the routine clinical practice in the sample of Italian 
hospitals enrolled in this survey with ESCRS guidelines and best available evidence, the use of 
cefuroxime at the end of surgery was lower than expected. Our survey shows that a greater 
proportion of centers that use cefuroxime have an acceptable incidence of endophthalmitis. 
The majority of surgeons in our survey (83%) said they would use cefuroxime if a preformulated 
preparation of cefuroxime for intracameral use were commercially available, according to the 
literature.
46
 
We cannot recommend or discourage the use of preoperative antibiotics, since no significant 
association were found in our survey,: however, when it was decided to use preoperative antibiotics 
fluoroquinolones were chosen.  
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WHAT WAS KNOWN 
 Although the ESCRS guidelines recommend to use cefuroxime at the end of surgery as a 
direct injection in the anterior chamber since 2007, its use gained slowly acceptance by the 
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scientific community in Italy, also correlated to the difficulties in preparing the antibiotic 
(risk of dilution errors, risk of bacterial contamination).  
 Pre-formulated cefuroxime commercially available “on label” formulation of cefuroxime 
were introduced in the European market since 2013.  
 However it is not clear whether the use of cefuroxime should be offered routinely to all 
patient undergoing cataract surgery or based on a risk assessment (local and systemic 
factors).  
WHAT THIS PAPER ADDS 
 Our Survey is the wider completed in Italy to collect information about the surgical routines 
with regards to prophylactic strategies and it is the first to report data about the use of 
cefuroxime in the anterior chamber in Italy.  
 Our Survey shows that a greater proportion of centers that use cefuroxime have an 
acceptable incidence of endophthalmitis (lower than 0.13%) 
 As no significant association were found in our Survey, we cannot recommend or 
discourage the use of preoperative antibiotics: however, when it was decided to use 
preoperative antibiotics fluoroquinolones were chosen.  
 
 
 
 
 
 
 
Appendix 
List of centres examined by Region (from North to South) 
NHS: National Health System   
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Piemonte 
 -Torino (NHS and University): Claudio Panico MD, Francesco Faraldi MD and  
 Savino D’Amelio MD  
 -Borgomanero (NHS): Vito Belloli MD, Vincenzo Ferrara MD 
 
Lombardia 
-Milano (University): Paolo Nucci MD, Edoardo Villani MD 
-Brescia (University): Francesco Semeraro MD 
- Milano (University): Matteo Cereda MD 
- Brescia (private hospital operating with NHS): Barbara Parolini MD 
-Milano (private hospital operating with NHS): Mario Romano MD 
Veneto 
-Venezia (NHS): Antonella Franch MD   
-Verona (University): Giorgio Marchini MD, Piero Ceruti MD 
-Treviso (NHS): Giuseppe Scarpa MD 
-Negrar (private hospital operating with NHS): Grazia Pertile MD, Guido Prigione MD 
   
Emilia Romagna 
-Reggio Emilia (NHS):  Luigi Fontana MD 
-Ravenna (NHS): Cesare Forlini MD 
-Parma (University): Nicola Ungaro MD 
            
Marche 
-Ancona (University): Cesare Mariotti M 
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Toscana 
-Pisa (NHS): Stanislao Rizzo MD, Francesco Barca MD 
-Pisa (University): Michele Figus MD       
   
Umbria 
 -Perugia (NHS): Tito Fiore MD 
Lazio 
 -Roma (NHS): Tommaso Rossi MD  
 
Campania 
-Acerra (private hospital operating with NHS): Aldo Gelso MD 
-Napoli (private hospital operating with NHS): Otello Gallo MD 
- Napoli (NHS): Beniamino Mastursi MD   
 - Pompei (private hospital operating with NHS): Dario Furgiuele MD 
  
Calabria 
-Catanzaro (University): Vincenzo Scorcia MD 
   
Sardegna 
 -Sassari (University): Francesco Boscia MD 
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